Exploring the role of interleukin-6 receptor blockade in epilepsy and associated neuropsychiatric conditions through a mendelian randomization study

Figure 4 Correlation between genetically mediated glycoprotein 130 levels and the risk of epilepsy. A: Forest plot illustrating mendelian randomization (MR) effect estimates and 95% confidence intervals (CI) for the impact of genetically mediated plasma protein levels of glycoprotein (gp) 130 on epilepsy; B: Forest plot displaying MR effect estimates and 95%CI for the impact of genetically mediated plasma protein levels of gp130 on generalized epilepsy; C: Forest plot displaying MR effect estimates and 95%CI for the impact of genetically mediated plasma protein levels of gp130 on focal epilepsy; D: Forest plot displaying MR effect estimates and 95%CI for the impact of genetically mediated plasma protein levels of gp130 on juvenile absence epilepsy, childhood absence epilepsy, and juvenile myoclonic epilepsy. SNP: Single nucleotide polymorphism; OR: Odds ratio; CI: Confidence intervals.